Drug shortages are a multifaceted issue; in recent years, it has become more prevalent with a direct impact on consumers, healthcare institutions, and governments. Pricing is part of the identified factors and the suggested solution for this issue, along with providing a favorable regulatory environment that improves and incentivizes stakeholders to maintain product availability, especially those old legacy essential drugs.

In this session, the panel will discuss several initiatives and policy changes that try to solve availability issues while considering affordability.

Session Material:

⬇️ PS9_session_slides_combined

⬇️ PS9_questions_answers_and_links